Perennial Allergic Rhinitis Par clinical trials

Explore recruiting perennial allergic rhinitis par clinical trials.

Recruiting perennial allergic rhinitis par studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Perennial Allergic Rhinitis Par trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lebrikizumab/ LY3650150 in Adult Participants With Perennial Allergic Rhinitis

Poland, Germany, Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Perennial Allergic Rhinitis Par trials by city

Perennial Allergic Rhinitis Par in Toronto Perennial Allergic Rhinitis Par in Vancouver Perennial Allergic Rhinitis Par in Montreal Perennial Allergic Rhinitis Par in Calgary Perennial Allergic Rhinitis Par in Edmonton Perennial Allergic Rhinitis Par in Ottawa Perennial Allergic Rhinitis Par in Winnipeg Perennial Allergic Rhinitis Par in Quebec City Perennial Allergic Rhinitis Par in Hamilton Perennial Allergic Rhinitis Par in Kitchener Perennial Allergic Rhinitis Par in London Perennial Allergic Rhinitis Par in Halifax Perennial Allergic Rhinitis Par in New York Perennial Allergic Rhinitis Par in Los Angeles Perennial Allergic Rhinitis Par in Chicago Perennial Allergic Rhinitis Par in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease